Review Article | Published:

Perivascular macrophages in health and disease

Nature Reviews Immunology (2018) | Download Citation


Macrophages are a heterogeneous group of cells that are capable of carrying out distinct functions in different tissues, as well as in different locations within a given tissue. Some of these tissue macrophages lie on, or close to, the outer (abluminal) surface of blood vessels and perform several crucial activities at this interface between the tissue and the blood. In steady-state tissues, these perivascular macrophages maintain tight junctions between endothelial cells and limit vessel permeability, phagocytose potential pathogens before they enter tissues from the blood and restrict inappropriate inflammation. They also have a multifaceted role in diseases such as cancer, Alzheimer disease, multiple sclerosis and type 1 diabetes. Here, we examine the important functions of perivascular macrophages in various adult tissues and describe how these functions are perturbed in a broad array of pathological conditions.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Additional information

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


  1. 1.

    Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in development, homeostasis and disease. Nature 496, 445–455 (2013).

  2. 2.

    Baer, C., Squadrito, M. L., Iruela-Arispe, M. L. & De Palma, M. Reciprocal interactions between endothelial cells and macrophages in angiogenic vascular niches. Exp. Cell Res. 319, 1626–1634 (2013).

  3. 3.

    Stefater, J. A. et al. Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature 474, 511–515 (2011).

  4. 4.

    Faraco, G., Park, L., Anrather, J. & Iadecola, C. Brain perivascular macrophages: characterization and functional roles in health and disease. J. Mol. Med. (Berl.) 95, 1143–1152 (2017).

  5. 5.

    Wang, X. N. et al. A three-dimensional atlas of human dermal leukocytes, lymphatics, and blood vessels. J. Invest. Dermatol. 134, 965–974 (2014).

  6. 6.

    Berry, M. & Clatworthy, M. R. Kidney macrophages: unique position solves a complex problem. Cell 166, 799–801 (2016).

  7. 7.

    Unanue, E. R., Ferris, S. T. & Carrero, J. A. The role of islet antigen presenting cells and the presentation of insulin in the initiation of autoimmune diabetes in the NOD mouse. Immunol. Rev. 272, 183–201 (2016).

  8. 8.

    Lewis, C. E., Harney, A. S. & Pollard, J. W. The multifaceted role of perivascular macrophages in tumors. Cancer Cell 30, 365 (2016).

  9. 9.

    Armulik, A. et al. Pericytes regulate the blood-brain barrier. Nature 468, 557–561 (2010).

  10. 10.

    Zhang, W. et al. Perivascular-resident macrophage-like melanocytes in the inner ear are essential for the integrity of the intrastrial fluid-blood barrier. Proc. Natl Acad. Sci. USA 109, 10388–10393 (2012). This study shows that PVMs in the stria vascularis of the cochlea regulate the permeability of the intrastrial fluid–blood barrier to maintain a normal electrolyte balance in the endolymph. This is essential for normal hearing.

  11. 11.

    Hickey, W. F. & Kimura, H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239, 290–292 (1988).

  12. 12.

    Zenker, D., Begley, D., Bratzke, H., Rubsamen-Waigmann, H. & von Briesen, H. Human blood-derived macrophages enhance barrier function of cultured primary bovine and human brain capillary endothelial cells. J. Physiol. 551, 1023–1032 (2003).

  13. 13.

    He, H. et al. Perivascular macrophages limit permeability. Arterioscler Thromb. Vasc. Biol. 36, 2203–2212 (2016). This paper shows that mesenteric PVMs are as abundant around capillaries as are pericytes and that their depletion results in vessel hyperpermeability. This effect could be rescued when M2-like macrophages, but not M1-like macrophages or dendritic cells, were reconstituted in vivo, which suggests that macrophages have subtype-specific roles in the regulation of vascular permeability.

  14. 14.

    Wiktor-Jedrzejczak, W. et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl Acad. Sci. USA 87, 4828–4832 (1990).

  15. 15.

    Stein, M., Keshav, S., Harris, N. & Gordon, S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287–292 (1992).

  16. 16.

    Wessel, F. et al. Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin. Nat. Immunol. 15, 223–230 (2014).

  17. 17.

    Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. & Hill, A. M. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166–6173 (2000).

  18. 18.

    Mato, N. et al. Involvement of specific macrophage-lineage cell surrounding arterioles in barrier and scavenger function in brain cortex. Proc. Natl Acad. Sci. USA 93, 3269–3274 (1996).

  19. 19.

    Mendes-Jorge, L. et al. Scavenger function of resident autofluorescent perivascular macrophages and their contribution to the maintenance of the blood-retinal barrier. Invest. Ophthalmol. Vis. Sci. 50, 5997–6005 (2009).

  20. 20.

    Stamatiades, E. G. et al. Immune monitoring of trans-endothelial transport by kidney-resident macrophages. Cell 166, 991–1003 (2016). The authors of this study identify a kidney-specific anatomical and functional unit formed by resident PVMs and peritubular capillaries. These PVMs detect and scavenge circulating immune complexes, which are delivered into the interstitium via transendothelial transport and trigger an FcγRIV-dependent inflammatory response with the consequent recruitment of monocytes and neutrophils.

  21. 21.

    Shi, X. Resident macrophages in the cochlear blood-labyrinth barrier and their renewal via migration of bone-marrow-derived cells. Cell Tissue Res. 342, 21–30 (2010).

  22. 22.

    Niemi, M., Sharpe, R. M. & Brown, W. R. Macrophages in the interstitial tissue of the rat testis. Cell Tissue Res. 243, 337–344 (1986).

  23. 23.

    Kaur, C., Wu, C. H. & Ling, E. A. Immunohistochemical and tracer studies of macrophages/microglia in the pineal gland of postnatal rats. J. Pineal Res. 22, 137–144 (1997).

  24. 24.

    Ferris, S. T. et al. A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes. Immunity 41, 657–669 (2014).

  25. 25.

    Calderon, B., Carrero, J. A., Miller, M. J. & Unanue, E. R. Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Proc. Natl Acad. Sci. USA 108, 1561–1566 (2011).

  26. 26.

    Vomund, A. N. et al. Beta cells transfer vesicles containing insulin to phagocytes for presentation to T cells. Proc. Natl Acad. Sci. USA 112, E5496–5502 (2015).

  27. 27.

    Mebius, R. E. & Kraal, G. Structure and function of the spleen. Nat. Rev. Immunol. 5, 606–616 (2005).

  28. 28.

    Aichele, P. et al. Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses. J. Immunol. 171, 1148–1155 (2003).

  29. 29.

    Gordon, S., Pluddemann, A. & Mukhopadhyay, S. Sinusoidal immunity: macrophages at the lymphohematopoietic interface. Cold Spring Harb. Perspect. Biol. 7, a016378 (2015).

  30. 30.

    Davies, L. C., Jenkins, S. J., Allen, J. E. & Taylor, P. R. Tissue-resident macrophages. Nat. Immunol. 14, 986–995 (2013).

  31. 31.

    Backer, R. et al. Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells. Proc. Natl Acad. Sci. USA 107, 216–221 (2010).

  32. 32.

    Pinto, A. R. et al. An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLOS One 7, e36814 (2012).

  33. 33.

    Junt, T. et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 450, 110–114 (2007).

  34. 34.

    Franke-Ullmann, G. et al. Characterization of murine lung interstitial macrophages in comparison with alveolar macrophages in vitro. J. Immunol. 157, 3097–3104 (1996).

  35. 35.

    De Falco, T. et al. Macrophages contribute to the spermatogonial niche in the adult testis. Cell Rep. 12, 1107–1119 (2015). This paper describes a subset of PVMs in the testis that make contact with blood vessels and lie on the surface of seminiferous tubules in apposition to areas of tubules containing undifferentiated spermatogonia. The transient depletion of these PVMs leads to reduced spermatogonial differentiation.

  36. 36.

    Moller, M., Rath, M. F. & Klein, D. C. The perivascular phagocyte of the mouse pineal gland: an antigen-presenting cell. Chronobiol. Int. 23, 393–401 (2006).

  37. 37.

    Gregerson, D. S. & Yang, J. CD45-positive cells of the retina and their responsiveness to in vivo and in vitro treatment with IFN-gamma or anti-CD40. Invest. Ophthalmol. Vis. Sci. 44, 3083–3093 (2003).

  38. 38.

    Roche, P. A. & Furuta, K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 15, 203–216 (2015).

  39. 39.

    Bedoret, D. et al. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J. Clin. Invest. 119, 3723–3738 (2009).

  40. 40.

    Winnall, W. R., Muir, J. A. & Hedger, M. P. Rat resident testicular macrophages have an alternatively activated phenotype and constitutively produce interleukin-10 in vitro. J. Leukoc. Biol. 90, 133–143 (2011).

  41. 41.

    Wang, M. et al. Characterization of the micro-environment of the testis that shapes the phenotype and function of testicular macrophages. J. Immunol. 198, 4327–4340 (2017).

  42. 42.

    Serrats, J. et al. Dual roles for perivascular macrophages in immune-to-brain signaling. Neuron 65, 94–106 (2010).

  43. 43.

    Schwandt, T. et al. Expression of type I interferon by splenic macrophages suppresses adaptive immunity during sepsis. EMBO J. 31, 201–213 (2012).

  44. 44.

    Honke, N. et al. Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat. Immunol. 13, 51–57 (2011).

  45. 45.

    Hickman, H. D. et al. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat. Immunol. 9, 155–165 (2008).

  46. 46.

    Miyake, Y. et al. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J. Clin. Invest. 117, 2268–2278 (2007).

  47. 47.

    McGaha, T. L., Chen, Y., Ravishankar, B., van Rooijen, N. & Karlsson, M. C. Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen. Blood 117, 5403–5412 (2011).

  48. 48.

    Steiniger, B., Barth, P., Herbst, B., Hartnell, A. & Crocker, P. R. The species-specific structure of microanatomical compartments in the human spleen: strongly sialoadhesin-positive macrophages occur in the perifollicular zone, but not in the marginal zone. Immunology 92, 307–316 (1997).

  49. 49.

    Chen, J. J., Lukyanenko, Y. & Hutson, J. C. 25-hydroxycholesterol is produced by testicular macrophages during the early postnatal period and influences differentiation of Leydig cells in vitro. Biol. Reprod. 66, 1336–1341 (2002).

  50. 50.

    Nes, W. D. et al. Identification of the lipophilic factor produced by macrophages that stimulates steroidogenesis. Endocrinology 141, 953–958 (2000).

  51. 51.

    Lukyanenko, Y., Chen, J. J. & Hutson, J. C. Testosterone regulates 25-hydroxycholesterol production in testicular macrophages. Biol. Reprod. 67, 1435–1438 (2002).

  52. 52.

    Oatley, J. M., Oatley, M. J., Avarbock, M. R., Tobias, J. W. & Brinster, R. L. Colony stimulating factor 1 is an extrinsic stimulator of mouse spermatogonial stem cell self-renewal. Development 136, 1191–1199 (2009).

  53. 53.

    Griswold, M. D. et al. Function of vitamin A in normal and synchronized seminiferous tubules. Ann. NY Acad. Sci. 564, 154–172 (1989).

  54. 54.

    Wu, R., Van der Hoek, K. H., Ryan, N. K., Norman, R. J. & Robker, R. L. Macrophage contributions to ovarian function. Hum. Reprod. Update 10, 119–133 (2004).

  55. 55.

    Brannstrom, M., Pascoe, V., Norman, R. J. & McClure, N. Localization of leukocyte subsets in the follicle wall and in the corpus luteum throughout the human menstrual cycle. Fertil. Steril. 61, 488–495 (1994).

  56. 56.

    Hume, D. A., Halpin, D., Charlton, H. & Gordon, S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: macrophages of endocrine organs. Proc. Natl Acad. Sci. USA 81, 4174–4177 (1984).

  57. 57.

    Gaytan, F. et al. Macrophages, cell proliferation, and cell death in the human menstrual corpus luteum. Biol. Reprod. 59, 417–425 (1998).

  58. 58.

    Care, A. S. et al. Macrophages regulate corpus luteum development during embryo implantation in mice. J. Clin. Invest. 123, 3472–3487 (2013).

  59. 59.

    Turner, E. C. et al. Conditional ablation of macrophages disrupts ovarian vasculature. Reproduction 141, 821–831 (2011).

  60. 60.

    Venneri, M. A. et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 109, 5276–5285 (2007).

  61. 61.

    De Palma, M., Venneri, M. A., Roca, C. & Naldini, L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 9, 789–795 (2003).

  62. 62.

    De Palma, M. et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, 211–226 (2005).

  63. 63.

    Ji, J. D. et al. The frequency of tumor-infiltrating tie-2-expressing monocytes in renal cell carcinoma: its relationship to angiogenesis and progression. Urology 82, 974.e9–974.e13 (2013).

  64. 64.

    Matsubara, T. et al. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis. Hepatology 57, 1416–1425 (2013).

  65. 65.

    Pucci, F. et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood “resident” monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 114, 901–914 (2009).

  66. 66.

    Murdoch, C., Tazzyman, S., Webster, S. & Lewis, C. E. Expression of Tie-2 by human monocytes and their responses to angiopoietin-2. J. Immunol. 178, 7405–7411 (2007).

  67. 67.

    Coffelt, S. B. et al. Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions. Cancer Res. 70, 5270–5280 (2010).

  68. 68.

    Mazzieri, R. et al. Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 19, 512–526 (2011).

  69. 69.

    Mossadegh-Keller, N. et al. Developmental origin and maintenance of distinct testicular macrophage populations. J. Exp. Med. 214, 2829–2841 (2017).

  70. 70.

    DeFalco, T., Bhattacharya, I., Williams, A. V., Sams, D. M. & Capel, B. Yolk-sac-derived macrophages regulate fetal testis vascularization and morphogenesis. Proc. Natl Acad. Sci. USA 111, E2384–E2393 (2014).

  71. 71.

    Fantin, A. et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116, 829–840 (2010).

  72. 72.

    Eubank, T. D., Galloway, M., Montague, C. M., Waldman, W. J. & Marsh, C. B. M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. J. Immunol. 171, 2637–2643 (2003).

  73. 73.

    Forget, M. A. et al. Macrophage colony-stimulating factor augments Tie2-expressing monocyte differentiation, angiogenic function, and recruitment in a mouse model of breast cancer. PLOS One 9, e98623 (2014).

  74. 74.

    Cortesi, F. et al. Bimodal CD40/Fas-Dependent Crosstalk between iNKT cells and tumor-associated macrophages impairs prostate cancer progression. Cell Rep. 22, 3006–3020 (2018).

  75. 75.

    Harney, A. S. et al. Real-time imaging reveals local, transient vascular permeability, and tumor cell intravasation stimulated by TIE2(hi) macrophage-derived VEGFA. Cancer Discov. 5, 932–943 (2015). The authors of this study show that VEGFA released by TIE2 hi PVMs reduces the number of tight junctions in tumour blood vessels, which transiently increases vascular permeability. This increases cancer cell intravasation at these sites and, in doing so, stimulates metastasis.

  76. 76.

    Ireland, L. et al. Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer. Oncogene 37, 2022–2036 (2018).

  77. 77.

    Rohan, T. E. et al. Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer. J. Natl Cancer Inst. 106, dju136 (2014).

  78. 78.

    Qian, B. Z. et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475, 222–225 (2011).

  79. 79.

    Qian, B. et al. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLOS One 4, e6562 (2009).

  80. 80.

    Hughes, R. et al. Perivascular M2 macrophages stimulate tumor relapse after chemotherapy. Cancer Res. 75, 3479–3491 (2015).

  81. 81.

    Welford, A. F. et al. TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. J. Clin. Invest. 121, 1969–1973 (2011).

  82. 82.

    Kioi, M. et al. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J. Clin. Invest. 120, 694–705 (2010).

  83. 83.

    Kozin, S. V. et al. Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation. Cancer Res. 70, 5679–5685 (2010).

  84. 84.

    Polfliet, M. M. et al. A method for the selective depletion of perivascular and meningeal macrophages in the central nervous system. J. Neuroimmunol. 116, 188–195 (2001).

  85. 85.

    Hawkes, C. A. & McLaurin, J. Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy. Proc. Natl Acad. Sci. USA 106, 1261–1266 (2009).

  86. 86.

    Elieh Ali Komi, D., Sharma, L. & Dela Cruz, C. S. Chitin and its effects on inflammatory and immune responses. Clin. Rev. Allergy Immunol. 54, 213–223 (2018).

  87. 87.

    Thanopoulou, K., Fragkouli, A., Stylianopoulou, F. & Georgopoulos, S. Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model. Proc. Natl Acad. Sci. USA 107, 20816–20821 (2010).

  88. 88.

    Park, L. et al. Brain perivascular macrophages initiate the neurovascular dysfunction of alzheimer Aβ peptides. Circ. Res. 121, 258–269 (2017).

  89. 89.

    Faraco, G. et al. Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension. J. Clin. Invest. 126, 4674–4689 (2016). This paper reports that PVMs in the brain promote alterations in neurovascular regulation in mouse models of hypertension. This effect is mediated by an increase in the permeability of the blood–brain barrier, which indicates that PVMs could be a therapeutic target in diseases associated with cerebrovascular oxidative stress.

  90. 90.

    Polfliet, M. M. et al. Meningeal and perivascular macrophages of the central nervous system play a protective role during bacterial meningitis. J. Immunol. 167, 4644–4650 (2001).

  91. 91.

    Steel, C. D. et al. Distinct macrophage subpopulations regulate viral encephalitis but not viral clearance in the CNS. J. Neuroimmunol. 226, 81–92 (2010).

  92. 92.

    Williams, K. C. et al. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J. Exp. Med. 193, 905–915 (2001).

  93. 93.

    Nowlin, B. T. et al. SIV encephalitis lesions are composed of CD163(+) macrophages present in the central nervous system during early SIV infection and SIV-positive macrophages recruited terminally with AIDS. Am. J. Pathol. 185, 1649–1665 (2015).

  94. 94.

    Filipowicz, A. R. et al. Proliferation of perivascular macrophages contributes to the development of encephalitic lesions in HIV-infected humans and in SIV-infected macaques. Sci. Rep. 6, 32900 (2016). This study examines the expression of the proliferation marker Ki-67 in the brains of uninfected and SIV-infected macaques with or without encephalitis. The authors find a significant increase in the number of proliferating PVMs in macaques with SIV encephalitis compared with that in uninfected and SIV-infected animals without encephalitis. These findings suggest a mechanism of viral accumulation in the brain through the proliferation of PVMs.

  95. 95.

    Kim, W. K. et al. CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am. J. Pathol. 168, 822–834 (2006).

  96. 96.

    Zhang, Z. et al. Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains. J. Neuroimmunol. 237, 73–79 (2011).

  97. 97.

    Polfliet, M. M. et al. The role of perivascular and meningeal macrophages in experimental allergic encephalomyelitis. J. Neuroimmunol. 122, 1–8 (2002).

  98. 98.

    Hofmann, N. et al. Increased expression of ICAM-1, VCAM-1, MCP-1, and MIP-1 alpha by spinal perivascular macrophages during experimental allergic encephalomyelitis in rats. BMC Immunol. 3, 11 (2002).

  99. 99.

    Jais, A. et al. Myeloid-cell-derived VEGF maintains brain glucose uptake and limits cognitive impairment in obesity. Cell 165, 882–895 (2016).

  100. 100.

    Cuff, C. A., Berman, J. W. & Brosnan, C. F. The ordered array of perivascular macrophages is disrupted by IL-1-induced inflammation in the rabbit retina. Glia 17, 307–316 (1996).

  101. 101.

    Gullapalli, V. K., Zhang, J., Pararajasegaram, G. & Rao, N. A. Hematopoietically derived retinal perivascular microglia initiate uveoretinitis in experimental autoimmune uveitis. Graefes Arch. Clin. Exp. Ophthalmol. 238, 319–325 (2000).

  102. 102.

    Zhang, J. et al. Lipopolysaccharide-induced middle ear inflammation disrupts the cochlear intra-strial fluid-blood barrier through down-regulation of tight junction proteins. PLOS One 10, e0122572 (2015).

  103. 103.

    Zhang, F. et al. Perivascular macrophage-like melanocyte responsiveness to acoustic trauma-a salient feature of strial barrier associated hearing loss. FASEB J. 27, 3730–3740 (2013).

  104. 104.

    Neng, L. et al. Structural changes in the strial blood–labyrinth barrier of aged C57BL/6 mice. Cell Tissue Res. 361, 685–696 (2015).

  105. 105.

    Abtin, A. et al. Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection. Nat. Immunol. 15, 45–53 (2014).

  106. 106.

    Inoshima, N., Wang, Y. & Bubeck Wardenburg, J. Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infection. J. Invest. Dermatol. 132, 1513–1516 (2012).

  107. 107.

    Sackstein, R., Falanga, V., Streilein, J. W. & Chin, Y. H. Lymphocyte adhesion to psoriatic dermal endothelium is mediated by a tissue-specific receptor/ligand interaction. J. Invest. Dermatol. 91, 423–428 (1988).

  108. 108.

    Natsuaki, Y. et al. Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin. Nat. Immunol. 15, 1064–1069 (2014).

  109. 109.

    Cao, Z. et al. Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis. Nat. Med. 22, 154–162 (2016).

  110. 110.

    Hu, B. & Phan, S. H. Notch in fibrosis and as a target of anti-fibrotic therapy. Pharmacol. Res. 108, 57–64 (2016).

  111. 111.

    Mohan, J. F. et al. Imaging the emergence and natural progression of spontaneous autoimmune diabetes. Proc. Natl Acad. Sci. USA 114, E7776–E7785 (2017).

  112. 112.

    Padgett, L. E., Burg, A. R., Lei, W. & Tse, H. M. Loss of NADPH oxidase-derived superoxide skews macrophage phenotypes to delay type 1 diabetes. Diabetes 64, 937–946 (2015).

  113. 113.

    Burg, A. R. et al. Superoxide production by NADPH oxidase intensifies macrophage antiviral responses during diabetogenic coxsackievirus infection. J. Immunol. 200, 61–70 (2018).

  114. 114.

    Ferris, S. T. et al. The islet-resident macrophage is in an inflammatory state and senses microbial products in blood. J. Exp. Med. 214, 2369–2385 (2017). This paper shows that in the pancreas, islet PVMs express a pro-inflammatory activation signature at steady state that supports diabetogenesis.

  115. 115.

    Filippi, C. M. & von Herrath, M. G. Viral trigger for type 1 diabetes. Diabetes 57, 2863–2871 (2008).

  116. 116.

    De Palma, M., Biziato, D. & Petrova, T. V. Microenvironmental regulation of tumour angiogenesis. Nat. Rev. Cancer 17, 457–474 (2017).

  117. 117.

    Gautier, E. L. et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13, 1118–1128 (2012).

  118. 118.

    Arwert, E. N. et al. A unidirectional transition from migratory to perivascular macrophage is required for tumor cell intravasation. Cell Rep. 23, 1239–1248 (2018).

  119. 119.

    Epelman, S. et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40, 91–104 (2014).

  120. 120.

    Goldmann, T. et al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat. Immunol. 17, 797–805 (2016).

  121. 121.

    Calderon, B. et al. The pancreas anatomy conditions the origin and properties of resident macrophages. J. Exp. Med. 212, 1497–1512 (2015).

  122. 122.

    Vanlandewijck, M. et al. A molecular atlas of cell types and zonation in the brain vasculature. Nature 554, 475–480 (2018).

  123. 123.

    Nakasone, E. S. et al. Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance. Cancer Cell 21, 488–503 (2012).

  124. 124.

    Cassier, P. A. et al. CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study. Lancet Oncol. 16, 949–956 (2015).

  125. 125.

    Ries, C. H. et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell 25, 846–859 (2014).

  126. 126.

    Cannarile, M. A. et al. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy. J. Immunother. Cancer 5, 53 (2017).

  127. 127.

    Kennedy, D. W. & Abkowitz, J. L. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90, 986–993 (1997).

  128. 128.

    Mildner, A. et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neurosci. 10, 1544–1553 (2007).

  129. 129.

    Zhu, Y. et al. Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression. Immunity 47, 323–338 (2017).

  130. 130.

    Klein, I. et al. Kupffer cell heterogeneity: functional properties of bone marrow-derived and sessile hepatic macrophages. Blood 110, 4077–4085 (2007).

  131. 131.

    Kohyama, M. et al. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 457, 318–321 (2009).

  132. 132.

    Wiegard, C. et al. Murine liver antigen presenting cells control suppressor activity of CD4+CD25+ regulatory T cells. Hepatology 42, 193–199 (2005).

  133. 133.

    Odegaard, J. I. et al. Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metab. 7, 496–507 (2008).

  134. 134.

    McCuskey, R. S. & McCuskey, P. A. Fine structure and function of Kupffer cells. J. Electron. Microsc. Tech. 14, 237–246 (1990).

  135. 135.

    Zeisel, A. et al. Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science 347, 1138–1142 (2015).

  136. 136.

    Fabriek, B. O. et al. CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation. Glia 51, 297–305 (2005).

  137. 137.

    Provis, J. M. et al. Human retinal microglia: expression of immune markers and relationship to the glia limitans. Glia 14, 243–256 (1995).

  138. 138.

    Byrne, A. J., Maher, T. M. & Lloyd, C. M. Pulmonary macrophages: a new therapeutic pathway in lung disease? Trends Mol. Med. 22, 303–316 (2016).

  139. 139.

    Zaba, L. C. et al. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J. Clin. Invest. 117, 2517–2525 (2007).

Download references


C.E.L. thanks Yorkshire Cancer Research, Prostate Cancer UK, Breast Cancer Now and the European Commission (MSCA-ITN-2015-ETN, project acronym ‘ISPIC’; and H2020-MSCA-RISE-2018, project acronym ‘Cancer’) for grant support of her work in this area. A.L. thanks Yorkshire Cancer Research for its support of his current work on perivascular macrophages in cancer. M.D.P. acknowledges grant support from the Swiss National Science Foundation (31003A-165963), Swiss Cancer League (KFS-3759-08-2015) and European Research Council (EVOLVE_725051).

Reviewer information

Nature Reviews Immunology thanks G. Faracco, L. Iruela-Arispe and the other anonymous reviewer(s) for their contribution to the peer review of this work.

Author information


  1. Department of Oncology & Metabolism, University of Sheffield Medical School, Sheffield, UK

    • Antonio Lapenna
    •  & Claire E. Lewis
  2. Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

    • Michele De Palma


  1. Search for Antonio Lapenna in:

  2. Search for Michele De Palma in:

  3. Search for Claire E. Lewis in:


A.L. and C.E.L. conceived the topic. All authors provided intellectual input and contributed to writing, reviewing and editing the article.

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to Claire E. Lewis.


Stria vascularis

A highly vascularized area in the lateral wall of the cochlea (a sensory organ of the inner ear) that produces endolymph and is responsible for generating the endocochlear potential that is required for the transduction of sound.

Blood–brain barrier

(BBB). A tightly regulated, protective, vascular interface that separates the peripheral blood and central nervous system.

Alternative (M2) macrophage activation

Activation to a group of polarized, anti-inflammatory phenotypes (M2a, M2b and M2c) that is induced by type 2 cytokines such as IL-4 and IL-13 (M2a), immune complexes and Toll-like receptor or IL-1 receptor ligands (M2b), and IL-10 and glucocorticoids (M2c).

Classical (M1) macrophage activation

Activation to a polarized, pro-inflammatory and antimicrobial phenotype that is induced by the type 1 cytokine interferon-γ, various microbial molecules (such as lipopolysaccharide) or other inflammatory cytokines (such as tumour necrosis factor and granulocyte–macrophage colony-stimulating factor).

Islets of Langerhans

Regions of the pancreas that contain the hormone-producing cells.

Reticuloendothelial system

A network of cells sharing a common function, namely, phagocytosis.

Bowman capsule

A cup-like sac at the beginning of the tubular component of a nephron in the mammalian kidney that encloses a cluster of microscopic blood vessels known as the glomerulus and filters the blood to form urine.

Dense core granules

Subcellular organelles in the β-cells of the pancreatic islets that store and release various peptide hormones, including insulin.

Subcapsular sinus

The space between the capsule and the cortex of a lymph node that enables the free movement of lymphatic fluid.


Capillaries with a fenestrated, discontinuous endothelium.

Seminiferous tubules

Structures in the testis that contain epithelium enveloping and supporting germ cells that are undergoing progressive differentiation and development into mature spermatozoa.

Leydig cells

Cells in the connective tissue between the seminiferous tubules that produce testosterone.

Corpus luteum

A temporary, hormone-secreting structure that develops in an ovary after an ovum has been discharged at ovulation.


Movement of cells through a basement membrane into a blood or lymphatic vessel.

Clodronate-containing liposomes

(CCLs). Synthesized liposomes containing the bisphosphonate clodronate, which kills macrophages when taken up by them.

Cerebral amyloid angiopathy

A condition in which β-amyloid is deposited around the small-sized and mid-sized arteries (and, sometimes, the veins) of the cerebral cortex.

Experimental autoimmune uveitis

A mouse or rat model of inflammation in the uveal component of the eye caused by an autoimmune reaction to self antigens.

About this article

Publication history